Loading...
NASDAQ: SEER
Seer, Inc.
Healthcare · Biotechnology
Market Cap
$96.76M
52w High
$2.41
52w Low
$1.62
P/E
-1.34
Volume
74.22K
Outstanding Shares
56.42M
Company profile
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome.
CEOOmid C. Farokhzad
SectorHealthcare
IndustryBiotechnology
Employees134
IPO dateDec 4, 2020
Valuation
Forward P/E—
EV/EBITDA-1.23
Enterprise value$81.5M
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth6.38%
Gross margin51.06%▲4.24%vs FY2024
Operating margin-470.45%▲34.45%vs FY2024
ROE-28.38%▼7.36%vs FY2024
Analyst consensus
RatingHold
Target price—
1
Buy
2
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 12, 2026
View
EPS
Actual vs estimate by quarter
Q1FY25
ActualEst.
-$0.34
-$0.37
Q3FY25
ActualEst.
-$0.32
-$0.32
Q4FY25
ActualEst.
-$0.29
-$0.32
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q1FY25
ActualEst.
$4.21M
$4.05M
Q3FY25
ActualEst.
$4.12M
$4.6M
Q4FY25
ActualEst.
$4.2M
$4.6M
Q1FY26
Next Est.
—